glp-1 ncbi Figure 7. [Structure of Receptor Agonists.]. - Endotext Glucagon-like peptide 1 (GLP-1) -

Any larger drops in the first few weeks are predominantly water, glycogen depletion, and reduced food volume in the digestive tract

Tirzepatide (Mounjaro) (Note: Technically a dual GLP-1/GIP agonist) Approved for diabetes, with weight loss benefits under clinical evaluation for obesity

Meng Z, Cheng Z

Foods that are not good for diabetics are what I can tolerate bread and pasta

Moreover, adverse effects of tirzepatide, such as gastrointestinal issues, could limit patient tolerance and broader adoption

The high-protein, portion-controlled approach supports muscle preservation and minimizes side effects common to all GLP-1 medications